Average Co-Inventor Count = 10.68
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (28 from 923 patents)
2. Cv Therapeutics, Inc. (10 from 105 patents)
3. G.d. Searle & Company (4 from 1,323 patents)
4. Pharmacia Corporation (3 from 200 patents)
5. Gilead Palo Alto, Inc. (2 from 15 patents)
6. The Endowment for Research in Human Biology, Inc. (1 from 10 patents)
47 patents:
1. 12404289 - 1'-cyano nucleoside analogs and uses thereof
2. 12258346 - Substituted 6-azabenzimidazole compounds
3. 12037342 - Substituted eneoxindoles and uses thereof
4. 11939347 - 1′-cyano nucleoside analogs and uses thereof
5. 11925631 - Substituted 6-azabenzimidazole compounds
6. 11897878 - Substituted 6-azabenzimidazole compounds
7. 11453681 - Substituted eneoxindoles and uses thereof
8. 11229638 - Therapeutic heterocyclic compounds
9. 11203591 - Substituted 6-azabenzimidazole compounds
10. 11186579 - Therapeutic heterocyclic compounds
11. 11071730 - Substituted 6-azabenzimidazole compounds
12. 11040033 - Therapeutic heterocyclic compounds
13. 10100058 - Fused heterocyclic compounds as CaM kinase inhibitors
14. 9695192 - Fused heterocyclic compounds as ion channel modulators
15. 9682998 - Fused heterocyclic compounds as ion channel modulators